Reipet – Lifestyle
Author:
Transpire Bio
Transpire Bio’s ANDA for Generic High-Strength Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
May 11, 2026
Transpire Bio Announces Opening of New Satellite R&D Facility in Shanghai, China
April 28, 2026
Transpire Bio Strengthens its Leadership Team with Appointment of Ewan Livesey as Head of Business Development
March 17, 2026